Trial Profile
A Phase I Randomized, Double-Blind, Placebo Controlled Dose Escalation Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Needle-free Dermal Injection to Cohorts of Adults Receiving Surgical Sternotomy Incisions
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs JVS 100 (Primary)
- Indications Scars
- Focus Adverse reactions
- Sponsors SironRX Therapeutics
- 17 Oct 2014 New trial record